Stevanato Group S.p.A (STVN) Income from Continuing Operations (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Income from Continuing Operations of 45938888.56 for Q1 2026, up 24.39% year-over-year from 36930610.79 in Q1 2025, and down 40.02% quarter-over-quarter from 76594063.27 in Q4 2025.
Stevanato Group S.p.A (STVN) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Income from Continuing Operations data on file, last reported at 45938888.56 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 45938888.56, up 24.39% year-over-year; the trailing twelve-month figure through Mar 2026 was 224224745.1 (up 23.06% YoY), and the FY2025 annual result was 162762384.44, up 29.32% from the prior year.
- Income from Continuing Operations eased to 45938888.56 in Q1 2026 per STVN's latest filing, from 76594063.27 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 76594063.27 in Q4 2025 and troughed at 27893424.73 in Q1 2024.
- A 5-year average of 49172135.56 and a median of 45938888.56 in 2026 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations jumped 75.73% in 2022, then tumbled 34.83% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 65091781.91 in 2022, then retreated by 2.81% to 63265266.65 in 2023, then grew by 9.11% to 69031262.85 in 2024, then gained by 10.96% to 76594063.27 in 2025, then plunged by 40.02% to 45938888.56 in 2026.
- Business Quant data shows STVN's Income from Continuing Operations at 45938888.56 in Q1 2026, 76594063.27 in Q4 2025, and 57432169.47 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 45.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.94 Mn |
| Dec 31, 2025 | 76.59 Mn |
| Sep 30, 2025 | 57.43 Mn |
| Jun 30, 2025 | 44.26 Mn |
| Mar 31, 2025 | 36.93 Mn |
| Dec 31, 2024 | 69.03 Mn |
| Sep 30, 2024 | 44.81 Mn |
| Jun 30, 2024 | 31.45 Mn |
| Mar 31, 2024 | 27.89 Mn |
| Dec 31, 2023 | 63.27 Mn |
| Sep 30, 2023 | 54.86 Mn |
| Jun 30, 2023 | 48.25 Mn |
| Mar 31, 2023 | 38.69 Mn |
| Dec 31, 2022 | 65.09 Mn |
| Sep 30, 2022 | 46.42 Mn |
| Jun 30, 2022 | 44.27 Mn |
| Mar 31, 2022 | 40.74 Mn |
| Dec 31, 2021 | 61.43 Mn |
| Sep 30, 2021 | 26.42 Mn |
| Jun 30, 2021 | 57.67 Mn |